Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis
Peter P. Youssef,David R. Haynes,Sophie Triantafillou,A. Parker,Jenny R. Gamble,Peter Roberts-Thomson,Michael Ahern,Malcolm D. Smith,Malcolm D. Smith +8 more
TL;DR: Alterations in TNFalpha expression in the synovial membrane correlated with clinical response to, and subsequent relapse after, MP therapy, which rapidly reduces IL-8 and TNF alpha levels in thesynovial compartment, with cytokine changes in the serum andSynovial fluid reflecting the changes inThe synovials.
read more
Abstract: Objective To establish whether the clinical efficacy of pulse methylprednisolone (MP; 1,000 mg intravenously) is related to the modulation of proinflammatory cytokines within the peripheral blood, synovial membrane, or synovial fluid compartments. Methods Eighteen patients with active rheumatoid arthritis (RA) were studied. Peripheral blood (11 patients) and knee synovial fluid (9 patients, 10 knees) were obtained before and at 4 and 24 hours after MP therapy. Interleukin-1beta (IL-1beta), IL-8, and tumor necrosis factor alpha (TNFalpha) were measured by enzyme-linked immunosorbent assay and biologic assays; prostaglandin E2 (PGE2) was measured by competitive radioimmunoassay. In 10 patients, arthroscopically directed synovial biopsies were obtained before and at 24 hours after treatment, at disease relapse (4 patients), and after retreatment (1 patient). Membranes were stained by immunohistochemical techniques with monoclonal antibodies against TNFalpha, IL-8, IL-1beta, and the IL-1 receptor antagonist protein (IL-1Ra). Results MP therapy was associated with a rapid (within 24 hours) and substantial decrease in the expression of TNFalpha in the lining and sublining regions of the synovial membrane, as well as substantial decreases in the levels of TNFalpha in serum and synovial fluid. There was also reduced IL-8 expression in the synovial lining, as well as reduced synovial fluid IL-8 levels. No effect on synovial membrane IL-1beta and IL-1Ra or synovial fluid IL-1beta and PGE2 was found. Conclusion MP therapy rapidly reduces IL-8 and TNFalpha levels in the synovial compartment, with cytokine changes in the serum and synovial fluid reflecting the changes in the synovial membrane. Alterations in TNFalpha expression in the synovial membrane correlated with clinical response to, and subsequent relapse after, MP therapy.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer
TL;DR: The glycoprotein YKL-40 was identified in 1989 to be secreted in vitro in large amount by the human osteosarcoma cell line MG63 and it has several names, but there will in the future be consensus of its name.
439
Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.
TL;DR: Recent insights relating to signaling, transcription processes, and gene expression as induced, inhibited, and/or modified by the interaction of GCs with their cytosolic receptors are reported, as well as relationships between dosages and plasma levels.
354
Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity.
Damien Loeuille,Isabelle Chary-Valckenaere,Jacqueline Champigneulle,Anne-Christine Rat,Frédéric Toussaint,Astrid Pinzano-Watrin,Jean Christophe Goebel,D. Mainard,Alain Blum,J. Pourel,Patrick Netter,Pierre Gillet +11 more
TL;DR: MRI evaluation of synovitis could be used to classify OA patients in clinical trials and could help to identify those who could benefit from synovium-targeted therapy.
307
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
Elli Kruithof,Dominique Baeten,Leen De Rycke,Bernard Vandooren,Dirk Foell,Johannes Roth,Juan D. Cañete,Annemieke M. H. Boots,Eric Veys,Filip De Keyser +9 more
TL;DR: Data indicate that the synovial histopathology of PsA, either oligoarticular or polyarticular, resembles that of other SpA subtypes, whereas both groups can be differentiated from RA on the basis of these samesynovial features, suggesting that peripheral synovitis in PsA belongs to the SpA concept.
270
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.
Dominique Baeten,Pieter Demetter,C Cuvelier,F. Van den Bosch,Elli Kruithof,N. Van Damme,Gust Verbruggen,H Mielants,Eric Veys,F De Keyser +9 more
TL;DR: The immune architecture of the synovial membrane is more dependent on local disease activity than on disease duration, and local and systemic disease activity, and diagnosis.
261
References
Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis
M J Elliott,Ravinder Nath Maini,Marc Feldmann,A Long-Fox,Peter Charles,H Bijl,James N. Woody +6 more
TL;DR: Repeat treatment with a chimeric monoclonal antibody to TNF alpha (cA2) in patients having disease flares may be useful therapy in the control of acute disease flares in rheumatoid arthritis and treatment programmes including cA2 may be effective in the long-term management of this disease.
737
Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid Arthritis
TL;DR: Using immunoaffinity-purified polyclonal anti-human recombinant tumor necrosis factor α (TNFα) F(ab′)2 fragments and immunohistochemical techniques, the cells that make TNFα were localized in the inflamed synovial tissue of patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
628
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA
Simon W. Lee,Ann-ping Tsou,Hardy W. Chan,Jan Thomas,Karen Petrie,Elsie M. Eugui,Anthony C. Allison +6 more
TL;DR: Inhibition of the formation and effects IL-1 is a mechanism by which glucocorticoids can exert antiinflammatory and immunosuppressive effects and kinetic analyses and pulse-labeling of mRNAs showed that glucoc Corticoids selectively decrease the stability of IL- 1 beta mRNA, without affecting the stabilityof beta-actin and FOS mRN as.
527
Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression.
TL;DR: Collectively, dexamethasone interfered with the binding of the most essential transcription factor, NF-kappa B, to its cognate cis-element, thereby suppressing the transcription of IL-8 gene.
446
•Journal Article
Synovial tissue macrophage as a source of the chemotactic cytokine IL-8.
Alisa E. Koch,S. L. Kunkel,J. C. Burrows,H. L. Evanoff,G. K. Haines,Richard M. Pope,Robert M. Strieter +6 more
TL;DR: The results suggest that macrophage-derived IL-8 may play an important role in the recruitment of PMN in synovial inflammation associated with RA.
328
Related Papers (5)
Frank C. Arnett,Steven M. Edworthy,Daniel A. Bloch,Dennis J. McShane,James F. Fries,Norman S. Cooper,L. A. Healey,Stephen R. Kaplan,Matthew H. Liang,Harvinder S. Luthra,Thomas A. Medsger,Donald M. Mitchell,David H. Neustadt,Robert S. Pinals,Jane G. Schaller,John T. Sharp,Ronald L. Wilder,Gene G. Hunder +17 more